- Report
- July 2023
- 115 Pages
Global
From €3415EUR$3,850USD£2,962GBP
- Report
- February 2021
- 420 Pages
United States
From €2129EUR$2,400USD£1,846GBP
- Report
- August 2024
- 100 Pages
Global
From €5277EUR$5,950USD£4,577GBP
- Report
- August 2024
- 100 Pages
Global
From €5277EUR$5,950USD£4,577GBP
- Report
- December 2022
- 100 Pages
Global
From €5277EUR$5,950USD£4,577GBP
- Report
- June 2024
- 120 Pages
Global
From €5277EUR$5,950USD£4,577GBP
- Report
- July 2025
- 200 Pages
Mexico
From €2208EUR$2,490USD£1,916GBP
- Report
- January 2024
- 200 Pages
Global
From €4435EUR$5,000USD£3,847GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3326EUR$3,750USD£2,885GBP
- Report
- June 2024
- 200 Pages
Global
From €7051EUR$7,950USD£6,116GBP
- Report
- March 2024
- 397 Pages
Global
From €7051EUR$7,950USD£6,116GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €2439EUR$2,750USD£2,116GBP
- Report
- July 2023
- 129 Pages
Global
From €6652EUR$7,500USD£5,770GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €2439EUR$2,750USD£2,116GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €2439EUR$2,750USD£2,116GBP
- Report
- April 2023
- 165 Pages
Global
From €6652EUR$7,500USD£5,770GBP
From €2439EUR$2,750USD£2,116GBP
- Report
- August 2022
- 30 Pages
Global
From €2883EUR$3,250USD£2,500GBP
- Report
- January 2022
- 60 Pages
Global
From €3503EUR$3,950USD£3,039GBP
- Report
- May 2024
- 138 Pages
Global
From €5764EUR$6,499USD£5,000GBP

The Antipsychotic Drug market is a segment of the Central Nervous System Drugs market. Antipsychotic drugs are used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These drugs work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis. Common side effects of antipsychotic drugs include drowsiness, weight gain, and dry mouth.
The Antipsychotic Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, and AstraZeneca. These companies have a wide range of products, including both branded and generic drugs. Additionally, many of these companies have developed new formulations of existing drugs, such as long-acting injectables, to improve patient compliance. Show Less Read more